ClinConnect ClinConnect Logo
Search / Trial NCT03964779

Prevalence of Thyroid Dysfunction and Anti-thyroid Antibodies in Infertile Women

Launched by CAIRO UNIVERSITY · May 24, 2019

Trial Information

Current as of May 13, 2025

Unknown status

Keywords

ClinConnect Summary

The study population will be divided into three groups:

* Group (A) consisting of 40 infertile women with either unexplained or anovulatory infertility with/without associated male factor of infertility,
* Group (B) consisting of 40 infertile women with tubal (mechanical) factor of infertility with/without associated male factor of infertility, and
* Group (C) consisting of 40 women with exclusive male factor of infertility and will be used as a control group.

. All women will be subjected to:
* Informed consent
* Full history taking, including age, duration of infertility and whether p...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • - Age: 18 - 38 years
  • Infertile women whether due to functional, anatomical, male factors OR unexplained OR combined factors
  • Exclusion Criteria:
  • - Age: below 18 and above 38 years
  • Patients with autoimmune diseases (such as lupus and rheumatoid arthritis)
  • Acute illness that require hospitalization
  • Patients on the following medications: steroids, dopamine, iodine, amiodarone, lithium, donperidone, thyroid hormone, and phenytoin.
  • Patients who work at night.

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Cairo, , Egypt

Patients applied

0 patients applied

Trial Officials

Ahmed Maged

Principal Investigator

Professor

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials